Diamine oxidase as a biomarker for depression and disease activity in inflammatory bowel disease: A cross-sectional observational study
World Journal of Psychiatry · 19.08.2025 · 15 (8)
DOI: 10.5498/wjp.v15.i8.106971 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift World Journal of Psychiatry, online erschienen am 19.08.2025. Verfasst von Su-Cong Lyu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hosp…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND Diamine oxidase (DAO) is secreted by epithelial cells in the intestinal villi, and its serum levels are elevated after intestinal mucosal damage. d-lactate (D-LA) is a gut microbial metabolite that can enter the systemic circulation if intestinal barrier function is impaired. Both DAO and D-LA are serum markers of small bowel mucosal integrity, and can be valuable biomarkers of intestinal barrier damage in inflammatory bowel disease (IBD). Intestinal barrier dysfunction was recently found to contribute to psychological symptoms in IBD patients. However, the correlations among DAO, D-LA, psychological symptoms, and disease activity in IBD remain unexplored. AIM To explore the correlations between serum markers of intestinal barrier dysfunction and psychological symptoms in IBD. METHODS We enrolled of 126 participants in this study. Psychological symptom questionnaires (depression, patient health questionnaire-9; anxiety, generalized anxiety disorder-7; and stress, perceived stress scale) and a quality of life (QOL) questionnaire (IBD questionnaire 32) were collected at the baseline. Serum DAO and D-LA levels were measured to assess intestinal barrier integrity. Receiver operating characteristic (ROC) curves were used to identify candidate markers of psychological symptoms and disease activity in IBD patients. Logistic regression was applied, with DAO as an independent variable for predicting psychological symptoms in IBD. RESULTS Serum DAO levels were significantly higher in IBD patients with moderate-to-severe psychological symptoms than in patients with mild or no psychological symptoms. DAO was positively correlated with depression and negatively correlated with QOL in IBD patients. ROC curves revealed that DAO was independently associated with psychological symptoms and clinical activity in patients with IBD. Additionally, logistic regression analysis revealed that each 1-ng/mL increase in DAO levels was significantly associated with an increased risk of psychological symptoms in IBD patients (OR: 1.019, 95%CI: 1.002-1.037). These results highlight the potential of DAO as a novel biomarker for both depression and disease activity in IBD patients. CONCLUSION This study indicates that DAO may be associated with depression and disease activity in IBD patients; however, prospective studies are required to validate its causal relationship.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Provinc…
- Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong Province, China.
- Department of Gastroenterology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518000, Guangdong Province, China.
- Department of Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, Guangdong Province, China.
- Integrative Microecology Clinical Center, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, Guangdong Province, China. yechen@smu.edu.cn.
Zitieren
APA
Lyu, S. C., Zhong, G. Q., Shi, R. J., Sun, Y., Li, J., Li, M. S., & Chen, Y. (2025). Diamine oxidase as a biomarker for depression and disease activity in inflammatory bowel disease: A cross-sectional observational study. World Journal of Psychiatry, 15(8). https://doi.org/10.5498/wjp.v15.i8.106971
Vancouver
Lyu SC, Zhong GQ, Shi RJ, Sun Y, Li J, Li MS, et al. Diamine oxidase as a biomarker for depression and disease activity in inflammatory bowel disease: A cross-sectional observational study. World Journal of Psychiatry. 2025;15(8). doi:10.5498/wjp.v15.i8.106971
BibTeX
@article{Lyu2025,
author = {Lyu, Su-Cong and Zhong, Guo-Qiang and Shi, Run-Jie and Sun, Yan and Li, Jin and Li, Ming-Song and Chen, Ye},
title = {Diamine oxidase as a biomarker for depression and disease activity in inflammatory bowel disease: A cross-sectional observational study},
journal = {World Journal of Psychiatry},
year = {2025},
volume = {15},
number = {8},
doi = {10.5498/wjp.v15.i8.106971}
}
EUVIMED